175 related articles for article (PubMed ID: 18836177)
41. The peptide loop consisting of amino acids 139-157 of human granzyme B (fragmentin 2) contains an immunodominant epitope recognized by the mouse.
Apostolidis VA; Browne KA; Smyth MJ; Trapani JA
Mol Immunol; 1995 Aug; 32(12):909-17. PubMed ID: 7565817
[TBL] [Abstract][Full Text] [Related]
42. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32.
Srinivasula SM; Fernandes-Alnemri T; Zangrilli J; Robertson N; Armstrong RC; Wang L; Trapani JA; Tomaselli KJ; Litwack G; Alnemri ES
J Biol Chem; 1996 Oct; 271(43):27099-106. PubMed ID: 8900201
[TBL] [Abstract][Full Text] [Related]
43. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis.
Van Damme P; Martens L; Van Damme J; Hugelier K; Staes A; Vandekerckhove J; Gevaert K
Nat Methods; 2005 Oct; 2(10):771-7. PubMed ID: 16179924
[TBL] [Abstract][Full Text] [Related]
44. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes.
Edwards KM; Kam CM; Powers JC; Trapani JA
J Biol Chem; 1999 Oct; 274(43):30468-73. PubMed ID: 10521426
[TBL] [Abstract][Full Text] [Related]
45. Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates.
Rukamp BJ; Kam CM; Natarajan S; Bolton BW; Smyth MJ; Kelly JM; Powers JC
Arch Biochem Biophys; 2004 Feb; 422(1):9-22. PubMed ID: 14725853
[TBL] [Abstract][Full Text] [Related]
46. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
47. Blessing or curse? Proteomics in granzyme research.
Joeckel LT; Bird PI
Proteomics Clin Appl; 2014 Jun; 8(5-6):351-81. PubMed ID: 24677694
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
[TBL] [Abstract][Full Text] [Related]
49. Proteolytic post-translational modification of proteins: proteomic tools and methodology.
Rogers LD; Overall CM
Mol Cell Proteomics; 2013 Dec; 12(12):3532-42. PubMed ID: 23887885
[TBL] [Abstract][Full Text] [Related]
50. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
[TBL] [Abstract][Full Text] [Related]
51. Hip is a pro-survival substrate of granzyme B.
Hostetter DR; Loeb CR; Chu F; Craik CS
J Biol Chem; 2007 Sep; 282(38):27865-74. PubMed ID: 17620340
[TBL] [Abstract][Full Text] [Related]
52. Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody.
Trapani JA; Browne KA; Dawson M; Smyth MJ
Biochem Biophys Res Commun; 1993 Sep; 195(2):910-20. PubMed ID: 8373425
[TBL] [Abstract][Full Text] [Related]
53. Single-Fluorescent Protein Reporters Allow Parallel Quantification of Natural Killer Cell-Mediated Granzyme and Caspase Activities in Single Target Cells.
Liesche C; Sauer P; Prager I; Urlaub D; Claus M; Eils R; Beaudouin J; Watzl C
Front Immunol; 2018; 9():1840. PubMed ID: 30135688
[TBL] [Abstract][Full Text] [Related]
54. Proteolysis of HIP during apoptosis occurs within a region similar to the BID loop.
Caruso JA; Reiners JJ
Apoptosis; 2006 Nov; 11(11):1877-85. PubMed ID: 17013759
[TBL] [Abstract][Full Text] [Related]
55. P-4 and RNKP-7, new granzyme-like serine proteases expressed in activated rat lymphocytes.
Ewoldt GR; Smyth MJ; Darcy PK; Harris JL; Craik CS; Horowitz B; Woodard SL; Powers JC; Hudig D
J Immunol; 1997 May; 158(10):4574-83. PubMed ID: 9144469
[TBL] [Abstract][Full Text] [Related]
56. Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity.
Demon D; Van Damme P; Vanden Berghe T; Deceuninck A; Van Durme J; Verspurten J; Helsens K; Impens F; Wejda M; Schymkowitz J; Rousseau F; Madder A; Vandekerckhove J; Declercq W; Gevaert K; Vandenabeele P
Mol Cell Proteomics; 2009 Dec; 8(12):2700-14. PubMed ID: 19759058
[TBL] [Abstract][Full Text] [Related]
57. Cascleave 2.0, a new approach for predicting caspase and granzyme cleavage targets.
Wang M; Zhao XM; Tan H; Akutsu T; Whisstock JC; Song J
Bioinformatics; 2014 Jan; 30(1):71-80. PubMed ID: 24149049
[TBL] [Abstract][Full Text] [Related]
58. Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis.
Trapani JA; Browne KA; Smyth MJ; Jans DA
J Biol Chem; 1996 Feb; 271(8):4127-33. PubMed ID: 8626751
[TBL] [Abstract][Full Text] [Related]
59. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
Eckhard U; Marino G; Butler GS; Overall CM
Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
[TBL] [Abstract][Full Text] [Related]
60. Characterisation of two serine protease inhibitors expressed in the pituitary gland.
Fell B; Smith AM; Hill RM; Parmar PK; Coates LC; Mezey E; Birch NP
Arch Physiol Biochem; 2002 Apr; 110(1-2):26-33. PubMed ID: 11935397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
